Amneal Pharmaceuticals, Inc. (AMRX)
NASDAQ: AMRX · Real-Time Price · USD
14.19
+0.51 (3.73%)
At close: Feb 2, 2026, 4:00 PM EST
14.29
+0.10 (0.70%)
Pre-market: Feb 3, 2026, 8:13 AM EST
Amneal Pharmaceuticals Market Cap
Amneal Pharmaceuticals has a market cap or net worth of $4.46 billion as of February 3, 2026. Its market cap has increased by 75.15% in one year.
Market Cap
4.46B
Enterprise Value
6.94B
1-Year Change
75.15%
Ranking
Category
Stock Price
$14.19
Market Cap Chart
Since May 7, 2018, Amneal Pharmaceuticals's market cap has increased from $1.91B to $4.46B, an increase of 133.96%. That is a compound annual growth rate of 11.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 4.30B | 8.57% |
| Dec 31, 2025 | 3.96B | 61.41% |
| Dec 31, 2024 | 2.45B | 31.88% |
| Dec 29, 2023 | 1.86B | 517.28% |
| Dec 30, 2022 | 301.44M | -57.87% |
| Dec 31, 2021 | 715.49M | 6.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 7, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hims & Hers Health | 6.17B |
| Alkermes | 5.60B |
| Lantheus Holdings | 4.44B |
| Kiniksa Pharmaceuticals International, | 3.33B |
| Prestige Consumer Healthcare | 3.10B |
| Supernus Pharmaceuticals | 2.76B |
| HUTCHMED (China) | 2.59B |
| Bausch Health Companies | 2.13B |